title: Asthma exacerbations and formoterol.
authors.forename: Richard W
authors.initials: RW
authors.lastname: Rissmiller
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Larj
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Peters
authors.forename: Eugene R
authors.initials: ER
authors.lastname: Bleecker
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001249:Asthma / Q000503:physiopathology*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage / Q000009:adverse effects*; D000068759:Formoterol Fumarate; D006801:Humans; D012107:Research Design; D000068299:Salmeterol Xinafoate
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D004983:Ethanolamines; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate